Skip to main content
. 2020 Jul 25;17(2):357–368. doi: 10.1007/s12015-020-10011-y

Table 1.

Interactions of EVs with microglia in homeostasis and development

EV type Recipient cell type Functional effect or interaction
Oligodendrocyte EVs (Oli-Neu EVs)

- Mixed primary and mono primary cultures

C3cr1/ EGFP labeled

Robust and specific uptake [38, 41]

PS-dependent specific uptake into microglia [38]

No change in morphology or cytokine expression [38]

Neuroblastoma EVs

(N2a EVs)

Primary microglia

BV2 mouse microglial line

Specific uptake into microglia and not primary neuronal cells [39]

Colocalization in vivo with 93% of IBA1 positive microglia at P2 and 80% at P7 [38]

Astrocyte derived EVs (ADEVs) Primary microglia

Internalized by microglia and trafficked to microglial endosomes [40].

Decreased microglial phagocytosis following morphine – exposed ADEV treatment [40].

Subventricular zone neural stem cell- derived extracellular vesicles (SVZ NSC) EVs In vivo microglia

Uptake into IBA1 and CD11b positive microglia [43].

Increase in CD11b expression and transition to rounded less complex cells [43].

Pheochromocytoma EVs (PC12 EVs) MG6 mouse microglial line

Enhanced ability of microglia to remove degenerating neurite from PC12 cells due to upregulation of complement component 3 (C3). [42].

No effect on phagocytosis of E Coli [42].

Murine lymphoblast EVs (EL-4) In vivo IB11+ microglia Colocalization with greater than 60% of IBA1+ cells after intranasal administration [44]